This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Protalix BioTherapeutics Inc (PLX)

AMEX: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 54.77M 86.40M 52.04M 27.00M
Receivables 1.88M 2.09M 1.41M 5.21M
Inventories 6.67M 7.96M 4.04M 279.00K
Other Current Assets 1.42M 1.46M 3.14M 0.00
Total Current Assets 65.52M 97.90M 61.17M 32.49M
Property, Plant & Equipment, Gross 32.74M 32.03M 31.10M 29.42M
Accumulated Depreciation & Depletion 21.45M 18.32M 14.79M 11.15M
Property, Plant & Equipment, Net 11.28M 13.71M 16.31M 18.27M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 1.67M 1.72M 1.25M 1.04M
Total Non-Current Assets 12.95M 15.43M 17.56M 19.31M
Liabilities & Shareholder Equity
Total Assets 78.47M 113.33M 78.73M 51.80M
Accounts Payable 4.45M 17.33M 6.83M 12.57M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 7.75M 0.00 5.71M 0.00
Total Current Liabilities 26.21M 26.70M 25.76M 18.69M
Long Term Debt 67.46M 67.05M 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 40.40M 46.54M 56.33M 59.19M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 107.86M 113.58M 56.33M 59.19M
Total Liabilities 134.07M 140.28M 82.08M 77.88M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity -55.60M -26.95M -3.36M -26.08M
Common Par 94.00K 93.00K 93.00K 86.00K
Additional Paid In Capital 185.63M 184.35M 180.14M 145.81M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -241.33M -211.38M -183.60M -171.98M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 11.86M 40.10M -3.36M -26.08M
Total Equity -55.60M -26.95M -3.36M -26.08M
Total Liabilities & Stock Equity 78.47M 113.33M 78.73M 51.80M
Total Common Shares Outstanding 93.60M 93.49M 93.49M 85.63M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 92.89M 92.37M 90.85M 84.65M
Diluted Weighted Shares Outstanding 92.89M 92.37M 90.85M 84.65M
Number of Employees 234 260 266 235
Number of Part-Time Employees 0 0 0 0
PLX News

PLX Protalix BioTherapeutics Inc

Analysts Ratings for PLX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 0 0
Moderate Buy 0 0 0 0
Hold 0 0 1 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET PLX ANALYST REPORT

Brokerage Partners

PLX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs